Background: We summarised data from studies reporting on macrolide and fluoroquinolone resistanceassociated mutations in Mycoplasma genitalium, examined temporal trends, and associations with geographical location, sex and population.
The goal of this study was to assess risk factors associated with HIV/AIDS progression. Between May 2007 and December 2014, 114 subjects were enrolled in Wuxi City and examined every 6 months. The pol gene sequence was amplified to ascertain the HIV-1 subtype. A Cox proportional hazards regression model was used to estimate the factors associated with HIV/AIDS progression. The median follow-up time for all 114 subjects was 26.70 months (IQR: 18.50-41.47), while the median progression time of the 38 progressed subjects was 24.80 months (IQR: 14.13-34.38). Overall, the CRF01_AE subtype was correlated with a significant risk of accelerated progression compared to non-CRF01_AE subtypes (HR = 3.14, 95%CI: 1.39-7.08, P = 0.006). In addition, a lower CD4 count (350-499) at baseline was associated with a risk of accelerated HIV/AIDS progression compared to higher CD4 count (≥500) (HR = 4.38, 95%CI: 1.95-9.82, P < 0.001). Furthermore, interaction analyses showed that HIV-1 subtypes interacted multiplicatively with transmission routes or CD4 count at baseline to contribute to HIV/AIDS progression (P = 0.023 and P < 0.001, respectively). In conclusion, the CRF01_AE subtype and a lower CD4 count at baseline tend to be associated with the faster progression of HIV/AIDS. Understanding the factors affecting HIV/AIDS progression is crucial for developing personalized management and clinical counselling strategies.Acquired immunodeficiency syndrome (AIDS) has been a major public health threat since its discovery in the United States in 1981. In general, the progression from human immunodeficiency virus (HIV) infection to AIDS development takes approximately 8-10 years 1 ; however, this duration varies among individuals. Multiple factors have been found to contribute to the progression of HIV-1 infection, such as immunological, virological and host genetic factors [2][3][4][5][6] . In particular, the emergence of RNA sequencing technologies has provided a means for analysing the association between virological factors and HIV/AIDS progression.The HIV-1 subtype has been associated with HIV/AIDS progression and has attracted much interest among researchers [7][8][9][10][11] . Unfortunately, no consensus has been reached in studies exploring the association between subtype and disease progression. Studies conducted in Tanzania and Uganda have suggested that subtype D is correlated with faster rates of CD4+ T-cell decline and disease progression than those observed in other subtypes and recombinant forms of the virus 7,8 . However, a retrospective cohort study conducted during 1996 and 2007 revealed that Africans infected with B clade HIV-1 suffered from faster rates of HIV/AIDS progression compared with those infected with non-B clade subtypes 10 . Furthermore, a meta-analysis demonstrated that the trend of HIV/AIDS progression among different HIV-1 subtypes in a descending order was subtype C > D > AE > G > A 9 . Though numerous prophylactic measures against HIV have been effectively employed in China 12 , they have not been able t...
Syphilis control programs have been scaled up due to the substantial burden in China. We analyzed syphilis incidence according to demographic, spatiotemporal, and economic factors. The increasing latent syphilis diagnoses and declining congenital syphilis suggest the effectiveness of scale-up screening. However, primary and secondary cases persist, especially in inland provinces.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.